EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice‐Switching Oligonucleotides

Miina Ojansivu iD, Hanna M G Barriga iD, Margaret N Holme iD, Stefanie Morf, James J Doutch iD, Samir El Andaloussi iD, Tomas Kjellman, Markus Johnsson, Justas Barauskas, Molly M Stevens iD

Advanced Materials · 2025-04 · 37 (17)

DOI: 10.1002/adma.202419538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 16.03.2025. Verfasst von Miina Ojansivu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden. Hauptthemen laut MEDLINE: Nanoparticles, Lipids, Oligonucleotides, Drug Carriers. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council Starting Grant, NSF, European Union's Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite increasing knowledge about the mechanistic aspects of lipid nanoparticles (LNPs) as oligonucleotide carriers, the structure‐function relationship in LNPs has been generally overlooked. Understanding this correlation is critical in the rational design of LNPs. Here, a materials characterization approach is utilized, applying structural information from small‐angle X‐ray scattering experiments to design novel LNPs focusing on distinct lipid organizations with a minimal compositional variation. The lipid phase structures are characterized in these LNPs and their corresponding bulk lipid mixtures with small‐angle scattering techniques, and the LNP‐cell interactions in vitro with respect to cytotoxicity, hemolysis, cargo delivery, cell uptake, and lysosomal swelling. An LNP is identified that outperforms Onpattro lipid composition using lipid components and molar ratios which differ from the gold standard clinical LNPs. The base structure of these LNPs has an inverse micellar phase organization, whereas the LNPs with inverted hexagonal phases are not functional, suggesting that this phase formation may not be needed for LNP‐mediated oligonucleotide delivery. The importance of stabilizer choice for the LNP function is demonstrated and super‐resolution microscopy highlights the complexity of the delivery mechanisms, where lysosomal swelling for the majority of LNPs is observed. This study highlights the importance of advanced characterization for the rational design of LNPs to enable the study of structure‐function relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesLipidsOligonucleotidesDrug CarriersHumansCationsScattering, Small AngleHemolysisLysosomes

Stichwörter der Autor:innen

drug deliverylipid nanoparticleoligonucleotidesmall angle scatteringstochastic optical reconstruction microscopy

Substanzen

LipidsOligonucleotidesCationsDrug Carriers

Autor:innen und Institutionen

  • Department of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden.
  • ISIS Neutron and Muon Source, Rutherford Appleton Laboratory, Harwell Campus, Oxfordshire, OX11 0QX, UK.
  • Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institute, Huddinge, 14152, Stockholm, Sweden.
  • Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, 141 86, Sweden.
  • Karolinska ATMP Center, Karolinska Institute, Huddinge, 14152, Stockholm, Sweden.
  • Camurus AB, Rydbergs torg 4, Lund, 224 84, Sweden.

ORCID-Profile: Miina Ojansivu, Hanna M G Barriga, Margaret N Holme, James J Doutch, Samir El Andaloussi, Molly M Stevens

Förderung

  • Swedish Research Council Starting Grant
  • NSF
  • European Union's Horizon 2020 research and innovation program
  • Cancerfonden
  • H2020 European Research Council
  • ISIS Neutron and Muon Source
  • Diamond Light Source
  • Oskar Huttusen säätiö

Zitieren

APA

Ojansivu, M., Barriga, H. M. G., Holme, M. N., Morf, S., Doutch, J. J., Andaloussi, S. E., Kjellman, T., Johnsson, M., Barauskas, J., & Stevens, M. M. (2025). Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice‐Switching Oligonucleotides. Advanced Materials, 37(17). https://doi.org/10.1002/adma.202419538

Vancouver

Ojansivu M, Barriga HMG, Holme MN, Morf S, Doutch JJ, Andaloussi SE, et al. Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice‐Switching Oligonucleotides. Advanced Materials. 2025;37(17). doi:10.1002/adma.202419538

BibTeX
@article{Ojansivu2025,
  author = {Ojansivu, Miina and Barriga, Hanna M G and Holme, Margaret N and Morf, Stefanie and Doutch, James J and Andaloussi, Samir El and Kjellman, Tomas and Johnsson, Markus and Barauskas, Justas and Stevens, Molly M},
  title = {Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice‐Switching Oligonucleotides},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {17},
  doi = {10.1002/adma.202419538}
}
Kostenlos starten →